TL
Therese Liechtenstein
Senior Investment Director, Biotech at M Ventures
TL
Therese Liechtenstein
Senior Investment Director, Biotech at M Ventures
Germany
Overview
Therese Liechtenstein is a Senior Investment Director at M Ventures with a strong background in biotech investments, having held various leadership roles in the industry. She has successfully invested in companies like DISCO Pharmaceuticals, Anavo Therapeutics, Altoida, Future Fertility, Theolytics, and FoRx Therapeutics, showcasing her expertise in nurturing and supporting innovative startups in the biotech sector.
Liechtenstein's career highlights include serving as a Board Member for multiple companies, such as ReproNovo, DISCO Pharmaceuticals GmbH, Theolytics, Anavo Therapeutics BV, FoRx Therapeutics, and Future Fertility, demonstrating her strategic leadership and commitment to driving growth and success in the biotech industry.
Work Experience
Senior Investment Director, Biotech
2024 - Current
Investment Director, Biotech
2022 - 2024
Principal, Biotech
2020 - 2022
Investment Associate, Biotech
2018 - 2020
Board Member
2023
Board Member
2022
Board Member
2021
Board Member
2020
Board Member
2019
Board Member
2021
Board Observer
2020
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Raised $165,000,000.00 from CRV, RA Capital Management, Pappas Capital, DCVC Bio, SoftBank Vision Fund, Pivotal bioVenture Partners, M Ventures, Surveyor Capital, Lux Capital and Neotribe Ventures.
Board Member
2021
Altoida is creating a new gold standard in brain health with Precision Neurology.
Raised $24,749,815.00 from M Ventures, VI Partners, Alpana Ventures, b2venture, Whitecap Venture Partners, FYRFLY Venture Partners, Hikma Ventures and HonorHealth.
Project Manager
2016 - 2018
Education
Doctor of Philosophy (PhD)
2012 - 2015
Master of Science (MSc)
2010 - 2012
Bachelor of Arts (BA)
2006 - 2010